Abstract: Injection molded article comprising at least 60 wt.-% of a heterophasic propylene copolymer, said polymer comprises a matrix being a polypropylene, said polypropylene comprises at least three polypropylene fractions, the three polypropylene fractions differ from each other by the melt flow rate and at least one of the three polypropylene fractions has a melt flow rate in the range of 1.0 to 20.0 g/10 min, and an elastomeric propylene copolymer dispersed in said matrix, wherein said heterophasic propylene copolymer has a melt flow rate of equal or more than 20.0 g/10 min and the amorphous phase of the xylene cold soluble fraction of the heterophasic propylene copolymer has an intrinsic viscosity of equal or higher than 2.0 dl/g.

Abstract: The invention pertains to a polypropylene composition consisting of: 55 to 79 wt % base polymer mix; 18 to 44.5 wt % talc; and 0.5 to 3 wt % additives based on the total weight of the polypropylene composition, the base polymer mix containing a XCU fraction and a XCS fraction and the XCU fraction being present in an amount of 91 to 98 wt % and the XCS fraction being present in an amount of 2 to 9 wt %; the base polymer mix containing a comonomer content of less than 5 wt % with respect to the base polymer mix; the talc having a d50 median particle size of 1.0 to 3.0 ?m when measured according to ISO 13317-3 15 using a Sedigraph; and the composition having a MFR (230° C./2.16 kg; ISO 1133) of 1 to 10 g/10 min. a process for the production of such a polypropylene composition and article comprising said polypropylene composition.

Abstract: Injection molded article comprising at least 60 wt.-% of a heterophasic propylene copolymer, said polymer comprises a matrix being a polypropylene, said polypropylene comprises at least three polypropylene fractions, the three polypropylene fractions differ from each other by the melt flow rate and at least one of the three polypropylene fractions has a melt flow rate in the range of 1.0 to 20.0 g/10 min, and an elastomeric propylene copolymer dispersed in said matrix, wherein said heterophasic propylene copolymer has a melt flow rate of equal or more than 20.0 g/10 min and the amorphous phase of the xylene cold soluble fraction of the heterophasic propylene copolymer has an intrinsic viscosity of equal or higher than 2.0 dl/g.

Abstract: The invention pertains to a polypropylene composition consisting of: 55 to 79 wt % base polymer mix; 18 to 44.5 wt % talc; and 0.5 to 3 wt % additives based on the total weight of the polypropylene composition, the base polymer mix containing a XCU fraction and a XCS fraction and the XCU fraction being present in an amount of 91 to 98 wt % and the XCS fraction being present in an amount of 2 to 9 wt %; the base polymer mix containing a comonomer content of less than 5 wt % with respect to the base polymer mix; the talc having a d50 median particle size of 1.0 to 3.0 ?m when measured according to ISO 13317-3 15 using a Sedigraph; and the composition having a MFR (230° C./2.16 kg; ISO 1133) of 1 to 10 g/10 min a process for the production of such a polypropylene composition and article comprising said polypropylene composition.

Abstract: A method and a device for discharging air current from a cooking area. The method and the device guide the air current through a sorption agent for absorbing water or water vapor contained in the air current. The sorption agent is regenerated preferably when the air current is not being discharged from the cooking area.

Abstract: A method and a device for discharging air current from a cooking area. The method and the device guide the air current through a sorption agent for absorbing water or water vapor contained in the air current. The sorption agent is regenerated preferably when the air current is not being discharged from the cooking area.

Abstract: The invention relates to the use of a preparation based on an antibody directed against a tumor-associated antigen, for producing a medicament for the intra-operative treatment of tumor patients, in particular for the prophylactic treatment to prevent the dissemination of tumor cells. The invention further relates to a kit for the intra-operative treatment of tumor patients, comprising the medicament and means for diagnostically determining malignant tumor cells.

Abstract: In an apparatus (1) having an adjustable adjustment slider (13) and having a second part (9) provided for adjusting the adjustment slider (13), provision is made for at least one coupling counterpart (16) to be present in the adjustment slider (13) and for the second part (9) to have a coupling piece (31) that can be coupled to the coupling counterpart (16) so that, when the second part (9) is not actuated, the coupling piece (31) is uncoupled from the coupling counterpart (16) in the adjustment slider (13) and, by actuating the second part (9), can be coupled to the coupling counterpart (16) to enable the adjustment slider (13) to be adjusted.

Abstract: In a hair-cutting system (1) including a hair-cutting apparatus (2) and including a comb device (3) at least the comb teeth (10) of the comb device (3) are connected to holding means (14) of the hair-cutting apparatus (2) with the aid of connecting means (13), and connecting means (13) are constructed to enable the angular position of the comb teeth (10) with respect of the hair-cutting apparatus (2) to be changed continually, and the connecting means (13) are further constructed and arranged in such a manner that when the comb teeth (10)are moved over a skin area of a person a continual contact with the skin area is guaranteed for the essential part of the contact zones (Z) of said comb teeth (10) by a continual adaptation of their angular position.